Bayforest Capital’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,193
Closed -$176K 882
2025
Q4
$176K Sell
2,193
-3,922
-64% -$328K 0.13% 320
2025
Q3
$597K Buy
6,115
+1,898
+45% +$153K 0.28% 94
2025
Q2
$294K Buy
4,217
+3,453
+452% +$197K 0.13% 303
2025
Q1
$37.9K Buy
+764
New +$48.3K 0.02% 589

Other funds holding ACLS

Bayforest Capital's ACLS Position: Q1 2026 in Review

Bayforest Capital sold out of Axcelis (ACLS) in Q1 2026, closing a stake of 2,193 shares — an estimated $176K sold.

Bayforest Capital first reported a position in ACLS in Q1 2025 and held it in 4 quarters. The position peaked at $597K in Q3 2025. 377 funds tracked by Wall St. Rank hold ACLS as of Q1 2026.

  • Bayforest Capital reported no remaining Axcelis position as of Q1 2026 after selling out during the quarter.
  • Bayforest Capital sold 2,193 Axcelis shares in Q1 2026, an estimated $176K.
  • Bayforest Capital first reported a position in Axcelis in Q1 2025 and held it in 4 quarters.
  • Bayforest Capital's Axcelis position peaked at $597K in Q3 2025.
  • 377 funds tracked by Wall St. Rank held Axcelis as of Q1 2026.

Based on Bayforest Capital's 13F filing for Q1 2026, filed 15 Apr 2026.